Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
第一作者:
Kevin,Wiehe
第一单位:
Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: kevin.wiehe@dm.duke.edu.
作者:
医学主题词
艾滋病疫苗(AIDS Vaccines);氨基酸序列(Amino Acid Sequence);动物(Animals);抗体, 病毒(Antibodies, Viral);抗体亲和力(Antibody Affinity);B-淋巴细胞(B-Lymphocytes);细胞, 培养的(Cells, Cultured);临床试验(主题)(Clinical Trials as Topic);保守序列(Conserved Sequence);表位作图(Epitope Mapping);表位, B淋巴细胞(Epitopes, B-Lymphocyte);HIV包膜蛋白质gp120(HIV Envelope Protein gp120);HIV感染(HIV Infections);HIV-1(HIV-1);人类(Humans);免疫球蛋白轻链(Immunoglobulin Light Chains);猕猴(Macaca mulatta);分子序列数据(Molecular Sequence Data);突变(Mutation);种系发生(Phylogeny);蛋白质结合(Protein Binding);蛋白质工程(Protein Engineering)
DOI
10.1016/j.immuni.2014.11.014
PMID
25526306
发布时间
2019-01-08
- 浏览33
Immunity
909-18页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



